Actively Recruiting
Evaluating Accuracy of Lactate Plus Meter and Accu-Chek Glucometer in Monitoring Glycogen Storage Disease Types Ia, Ib, and XI
Led by Connecticut Children's Medical Center · Updated on 2026-10-29
10
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the accuracy of two home monitoring devicesthe Lactate Plus meter and the Accu-Chek Guide glucometerin patients diagnosed with Glycogen Storage Disease Types Ia, Ib, and XI. The study aims to compare these devices readings with lab serum measurements to see if they fall within 20% of lab results 95% of the time. This observational study focuses on improving patient monitoring techniques for this rare condition. Participants will have a planned hospital admission lasting about 8 hours during which they will undergo hourly blood draws and finger-stick tests. The Lactate Plus meter will be used to measure blood lactate levels, and the Accu-Chek Guide glucometer will be used to measure blood glucose levels at the same hourly intervals. These procedures provide simultaneous device and lab measurements for comparison. During the study visit, participants will receive hourly assessments including blood sampling and finger-sticks over the 8-hour period. Researchers will evaluate the accuracy of the home devices compared to laboratory serum levels for both lactate and glucose. The primary outcome is to verify if device readings align closely with lab results. The study will also monitor participant safety and adherence during this single observation session.
CONDITIONS
Brief Title
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
Research Team
M
Malaya Mount, MS, RD, CDN
M
Malaya Mount
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here